Stock listing
Ernexa Therapeutics Inc.
Selected listing: ERNA · NASDAQ · USD · US
Ernexa Therapeutics Inc. (NASDAQ:ERNA), Health Technology. Latest release Oct 1, 2026: Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J.…
- Ticker
- NASDAQ:ERNA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc. is a public company traded under the ticker ERNA in the American market. Ernexa Therapeutics focuses on developing innovative therapeutic solutions.
Latest news from Ernexa Therapeutics Inc.
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
October 1, 2026
Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic
September 30, 2026
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
September 29, 2026
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
September 28, 2026
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
September 17, 2026
Research Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc. company profile
View the public company page for Ernexa Therapeutics Inc. on 6ix.
Ernexa Therapeutics Inc. news
Read company news and market updates connected to Ernexa Therapeutics Inc..
Ernexa Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Ernexa Therapeutics Inc..